81 related articles for article (PubMed ID: 37322876)
1. Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK.
Trachsel B; Valpreda G; Lutz A; Schibli R; Mu L; Béhé M
EJNMMI Radiopharm Chem; 2023 Sep; 8(1):21. PubMed ID: 37665477
[TBL] [Abstract][Full Text] [Related]
2. Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies.
Suzuki H; Kannaka K; Uehara T
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675468
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and Therapeutic Radiopharmaceuticals: A "Hot" Topic.
Lindsley CW; Müller CE; Bongarzone S
ACS Pharmacol Transl Sci; 2024 Jan; 7(1):1-7. PubMed ID: 38230278
[No Abstract] [Full Text] [Related]
4. [Design of radiolabeled antibody fragments for tumor-selective radioactivity localization--brush border enzyme-sensitive bond to decrease renal accumulation of radioactivity].
Mukai T; Fujioka Y; Arano Y; Saji H
Yakugaku Zasshi; 2003 Aug; 123(8):647-52. PubMed ID: 12931660
[TBL] [Abstract][Full Text] [Related]
5. Renal brush border strategy: A developing procedure to reduce renal radioactivity levels of radiolabeled polypeptides.
Arano Y
Nucl Med Biol; 2021 Jan; 92():149-155. PubMed ID: 32169305
[TBL] [Abstract][Full Text] [Related]
6. Reduction of the Renal Radioactivity of
Suzuki H; Araki M; Tatsugi K; Ichinohe K; Uehara T; Arano Y
J Med Chem; 2023 Jul; 66(13):8600-8613. PubMed ID: 37322876
[TBL] [Abstract][Full Text] [Related]
7. Reduction of the hepatic radioactivity levels of [
Suzuki H; Matsukawa M; Madokoro R; Terasaka Y; Kannaka K; Uehara T
Nucl Med Biol; 2024; 132-133():108910. PubMed ID: 38636351
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of [188Re]organorhenium-labeled antibody fragments with renal enzyme-cleavable linkage for low renal radioactivity levels.
Uehara T; Koike M; Nakata H; Hanaoka H; Iida Y; Hashimoto K; Akizawa H; Endo K; Arano Y
Bioconjug Chem; 2007; 18(1):190-8. PubMed ID: 17226973
[TBL] [Abstract][Full Text] [Related]
9. Renal Handling of
Uehara T; Kanazawa N; Suzuki C; Mizuno Y; Suzuki H; Hanaoka H; Arano Y
Bioconjug Chem; 2020 Nov; 31(11):2618-2627. PubMed ID: 33085454
[TBL] [Abstract][Full Text] [Related]
10. Renal brush border enzyme-cleavable linkages for low renal radioactivity levels of radiolabeled antibody fragments.
Akizawa H; Imajima M; Hanaoka H; Uehara T; Satake S; Arano Y
Bioconjug Chem; 2013 Feb; 24(2):291-9. PubMed ID: 23330714
[TBL] [Abstract][Full Text] [Related]
11. A Gallium-67/68-Labeled Antibody Fragment for Immuno-SPECT/PET Shows Low Renal Radioactivity Without Loss of Tumor Uptake.
Uehara T; Yokoyama M; Suzuki H; Hanaoka H; Arano Y
Clin Cancer Res; 2018 Jul; 24(14):3309-3316. PubMed ID: 29666303
[No Abstract] [Full Text] [Related]
12. Enzymological Characterization of
Brandt F; Ullrich M; Wodtke J; Kopka K; Bachmann M; Löser R; Pietzsch J; Pietzsch HJ; Wodtke R
J Med Chem; 2023 Jan; 66(1):516-537. PubMed ID: 36595224
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of a para-carboxylated benzyl-DOTA for labeling peptides and polypeptides.
Suzuki H; Ichinohe K; Araki M; Muramatsu S; Uehara T; Arano Y
Nucl Med Biol; 2022; 114-115():18-28. PubMed ID: 36088873
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeled Antibodies for Cancer Imaging and Therapy.
Parakh S; Lee ST; Gan HK; Scott AM
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326605
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
